Major Trial of Monkeypox Treatment TPOXX to Launch in Africa
MONDAY, Oct. 17, 2022 (HealthDay News) — The ability of TPOXX to treat people infected with monkeypox is being directly tested in a new clinical trial in central Africa, U.S. health officials have announced. TPOXX — the antiviral drug tecovirimat — is only approved to treat smallpox, but doctors haveContinue Reading